Journal article
Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials
Abstract
OBJECTIVES: This study evaluated data from 3 federally funded trials that focused on optimal medical therapy to determine if formalized attempts at risk factor control within clinical trials are effective in achieving guideline-driven treatment goals for diabetic patients with coronary artery disease (CAD).
BACKGROUND: Despite clear evidence of benefit for CAD secondary prevention, the level of risk factor control in clinical practice has been …
Authors
Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ
Journal
Journal of the American College of Cardiology, Vol. 61, No. 15, pp. 1607–1615
Publisher
Elsevier
Publication Date
4 2013
DOI
10.1016/j.jacc.2013.01.044
ISSN
0735-1097
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAngioplasty, Balloon, CoronaryCardiovascular AgentsCholesterol, LDLComorbidityCoronary Artery BypassCoronary Artery DiseaseDiabetes Mellitus, Type 2Effect Modifier, EpidemiologicFemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMiddle AgedMonitoring, PhysiologicOutcome and Process Assessment, Health CarePractice Guidelines as TopicRisk FactorsRisk Reduction BehaviorSecondary PreventionSmoking Cessation